Teams link: Join the meeting now

Meeting ID: 277 080 580 861 9

Passcode: nk3a6S6b

Learning Objectives: 

• Describe the mechanisms that contribute to cancer-associated venous thromboembolic disease including tumor-related, treatment-related, and patient-related risk factors​

• Summarize current recommendations for anticoagulation for treatment and prevention of cancer-associated venous thromboembolic disease ​

• Compare anticoagulant options—including LMWH, DOACs, and warfarin—and identify situations where one agent is preferred